Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer
This study is currently recruiting participants.
Verified January 2013 by Adamis Pharmaceuticals Corporation
Sponsor:
Adamis Pharmaceuticals Corporation
Information provided by (Responsible Party):
Adamis Pharmaceuticals Corporation
ClinicalTrials.gov Identifier:
NCT01436214
First received: August 31, 2011
Last updated: January 22, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2015 |
| Estimated Primary Completion Date: | August 2014 (Final data collection date for primary outcome measure) |